CBD shows promise for migraines, but the evidence so far suggests it works best when combined with at least a small amount of THC rather than on its own. In the largest randomized trial to date, CBD-dominant cannabis provided pain relief at the one-hour mark but failed to outperform placebo by the two-hour point. The combination of CBD and THC, however, more than doubled the rate of complete pain freedom compared to placebo. So the short answer is: CBD may help, but probably not as a solo act.
What the Clinical Evidence Actually Shows
A randomized, double-blind, placebo-controlled trial tested three vaporized cannabis formulations against placebo for acute migraine attacks: a THC-dominant product, a CBD-dominant product, and a combined THC-plus-CBD product. The results tell a clear story about where CBD fits.
At one hour, the CBD-dominant formulation did provide meaningful relief. About 59% of participants reported less pain, compared to 37% on placebo. But by the critical two-hour mark, that advantage had faded. Only 53% of the CBD-dominant group reported pain relief versus 47% on placebo, a gap that was no longer statistically significant. CBD alone also failed to beat placebo for complete pain freedom or relief from the most bothersome migraine symptom (like nausea or light sensitivity).
The combined THC-plus-CBD formulation performed significantly better across nearly every measure. At two hours, 67% achieved pain relief (versus 47% for placebo), and 35% were completely pain-free (versus 16%). Perhaps most notably, 60% experienced freedom from their most bothersome symptom, compared to 34% on placebo. These benefits held up over time: at 24 hours, the combined group maintained pain freedom at more than double the rate of placebo.
Why CBD Alone Falls Short
CBD interacts with your body’s pain and inflammation systems through several pathways. It activates serotonin receptors involved in migraine signaling and stimulates pain-sensing channels in a way that can ultimately reduce their sensitivity. It also slows the breakdown of your body’s own cannabis-like molecules (endocannabinoids) by blocking the enzyme that degrades them, which lets those natural pain-relieving compounds stick around longer.
The problem is that these effects appear to be modest on their own. Migraine involves multiple overlapping systems, including serotonin signaling, inflammatory cascades, and the sensory nerve pathways that cause throbbing pain and light sensitivity. CBD touches several of these, but it doesn’t strongly activate the cannabinoid receptors (CB1) that THC targets, and those receptors play a central role in acute pain modulation. This is likely why the combination outperforms CBD alone: THC handles the direct pain suppression while CBD contributes anti-inflammatory and serotonin-related effects, and may also soften the psychoactive intensity of THC.
Animal research supports this pairing. In mouse models of migraine, a 100:1 ratio of CBD to THC reduced light sensitivity and facial pain responses triggered by CGRP, one of the key molecules involved in migraine attacks. Even a tiny amount of THC alongside a large dose of CBD appears to unlock benefits that neither compound achieves alone.
CBD for Migraine Prevention
While the acute treatment data is mixed for CBD alone, the prevention picture looks more encouraging for cannabis-based approaches generally. A retrospective study of 121 patients in Colorado using medical cannabis found that 85% experienced fewer migraines over an average follow-up of nearly two years. A separate cross-sectional study in Israel reported that more than 60% of patients using medical cannabis achieved long-term reductions in migraine frequency alongside less disability and lower use of other migraine medications.
In one prophylaxis trial, patients with chronic migraines who took 200 mg daily of a THC-plus-CBD combination for three months saw migraine intensity drop by 55%. That same combination outperformed amitriptyline, a commonly prescribed preventive medication, by roughly 40%. Again, though, these results involved THC alongside CBD, not CBD in isolation. No well-designed trial has tested daily CBD-only use as a migraine preventive.
Side Effects and Drug Interactions
About 21% of headache patients using cannabis-based products report side effects. The most common are fatigue and lethargy (19%), anxiety (11%), changes in appetite (11%), and, ironically, worsening headache (9%). Less frequent complaints include brain fog, nausea, and paranoia. These rates include products containing THC, which likely accounts for the anxiety and paranoia reports.
One advantage of CBD-dominant products is a lower psychoactive effect. In the clinical trial, participants using the CBD-dominant formulation rated their subjective “highness” at 1.5 out of 10, compared to 3.5 for THC-dominant and 2.4 for the combination. If avoiding intoxication matters to you, a high-CBD, low-THC product offers a middle ground.
The more serious concern is drug interactions. CBD inhibits several liver enzymes responsible for processing common medications. It strongly interferes with CYP2C19, the enzyme that breaks down certain anti-seizure drugs, proton pump inhibitors, and some antidepressants. In one study, chronic CBD use increased blood levels of a seizure medication by 240%. It also affects enzymes that process blood thinners, blood pressure medications, and even caffeine. If you take triptans, antidepressants, beta-blockers, or blood thinners for your migraines or related conditions, CBD could alter how those drugs work in your body, potentially raising their levels to problematic concentrations.
Choosing a Product and Delivery Method
Delivery method matters for migraine relief because speed matters during an attack. Vaporized cannabis provided noticeable pain relief within one hour in clinical trials. Sublingual oils (held under the tongue) typically absorb faster than capsules or edibles, which must pass through the digestive system first. If you’re using CBD for an active migraine, an edible taken on a full stomach may not kick in quickly enough to be useful.
Full-spectrum CBD products contain small amounts of THC along with other cannabinoids and plant compounds. Given that the clinical data consistently favors CBD-plus-THC over CBD alone, full-spectrum formulations are likely more effective than CBD isolate for migraine. This concept, sometimes called the entourage effect, suggests the plant’s various components work better together. Full-spectrum products also contain CBDA, another cannabinoid that may help with nausea, a common migraine symptom.
Dosing remains uncertain because no standardized CBD-only protocol exists for migraines. The prophylaxis research used 200 mg daily of a THC-CBD combination, which is substantially higher than what most over-the-counter CBD products deliver per serving. Many commercial CBD oils contain 10 to 50 mg per dose. Whether these lower amounts meaningfully affect migraines is unknown, and the gap between retail product dosing and clinical research dosing is one of the biggest unanswered questions in this space.
The Bottom Line on CBD and Migraines
CBD alone provides fast but short-lived migraine relief that fades to placebo-level effectiveness within two hours. Combined with even small amounts of THC, the picture changes substantially: pain freedom doubles, bothersome symptoms like nausea and light sensitivity improve, and benefits hold for 24 to 48 hours. For prevention, cannabis-based products containing both compounds show the strongest evidence, with the majority of patients in observational studies reporting fewer monthly migraines. If you’re considering CBD for migraines, a full-spectrum product with some THC content is more likely to help than pure CBD isolate, but the interaction risk with other medications is real and worth reviewing with whoever manages your prescriptions.